Nicox

en fr

About Us
Pipeline, Markets and Science
Investors
News and Events
Contact Us

Nicox completes phase I clinical trial in UK of its anti-inflammatory HCT-1026. Patents granted in US and Europe covering HCT-1026

April 24, 1997

← Back to blog page

Nicox

Contact Us
Subscribe to news
Legal Notice

Search

© Copyright Nicox, all rights reserved

Cookies

By continuing to use this website, you agree to our Cookie Policy.